治験管理システム市場レポート:コンポーネント別(ソフトウェア、サービス)、展開形態別(ウェブベースCTMS、オンプレミス、クラウドベースCTMS)、エンドユーザー別(製薬・バイオテクノロジー企業、医薬品開発業務受託機関、その他)、地域別 2024-2032

治験管理システム市場レポート:コンポーネント別(ソフトウェア、サービス)、展開形態別(ウェブベースCTMS、オンプレミス、クラウドベースCTMS)、エンドユーザー別(製薬・バイオテクノロジー企業、医薬品開発業務受託機関、その他)、地域別 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A15003

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Clinical Trial Management Systems Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Component
    6.1    Software
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Services
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Deployment Mode
    7.1    Web-based CTMS
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    On-premise
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Cloud-based CTMS
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by End User
    8.1    Pharmaceutical and Biotechnology Firms
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Contract Research Organizations
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Advarra Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    ArisGlobal LLC
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    BioClinica Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 SWOT Analysis
        14.3.4    DataTrak International Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    DZS Clinical Services Inc. (WDB Holdings Co. Ltd.)
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    International Business Machines Corporation
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Medidata Solutions Inc. (Dassault Systèmes SE)
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 SWOT Analysis
        14.3.8    MedNet Solutions Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Oracle Corporation
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Parexel International Corporation
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 SWOT Analysis
        14.3.11    RealTime Software Solutions LLC
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
        14.3.12    Veeva Systems Inc.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials
           14.3.12.4 SWOT Analysis

治験管理システム市場レポート:コンポーネント別(ソフトウェア、サービス)、展開形態別(ウェブベースCTMS、オンプレミス、クラウドベースCTMS)、エンドユーザー別(製薬・バイオテクノロジー企業、医薬品開発業務受託機関、その他)、地域別 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials